New combo pills for high blood pressure under Real-World study
NCT ID NCT05413057
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This large observational study will follow 20,000 adults with essential hypertension who are prescribed one of two combination pills containing fimasartan. The main goal is to see how well these pills control blood pressure over 12 weeks, and a longer follow-up of up to 2 years will check for heart events and safety. Participants take their medication as part of routine care, and researchers collect data on effectiveness and side effects.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
fimasartan/amlodipine or fimasartan/amlodipine/hydrochlorothiazide (single-pill combinations)
What this could lead to
If successful, this study could confirm that these combination pills effectively control blood pressure and reduce long-term heart risks in people with essential hypertension.
What could go wrong
This is an observational study, not a controlled trial, so results may be less reliable. Side effects are possible, and the 12-week main phase is too short to assess long-term safety or outcomes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERTENSION,ESSENTIAL are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Seoul National University Bundang Hospital
RECRUITINGSeoul, South Korea
Contact
Contact